CannTrust stock falls after voluntary halt of all cannabis sales, shipments

VAUGHAN, Ont. – Shares of CannTrust Holdings Inc. fell as much as 11 per cent after the cannabis company announced it was voluntarily halting all sales and shipments amid Health Canada’s investigation.

CannTrust’s stock was trading at $3.90 on the Toronto Stock Exchange at mid-morning, down 11.1 per cent from its previous close of $4.04.

READ MORE: CannTrust, ‘leading’ medical cannabis provider, halts sales amid Health Canada probe

Story continues below

That’s sharply down from its $6.46 closing price last Friday, before CannTrust announced on Monday that it was notified by Health Canada about unlicensed cultivation at its Ontario greenhouse in rooms which had yet to receive government approval.

CannTrust said Monday that Health Canada put 5,200 kilograms of cannabis on hold and it voluntarily put another 7,200 kilograms of product on hold, but would continue with cultivation and sales.

READ MORE: Ontario Cannabis Store pulls affected CannTrust products amid Health Canada probe

But late yesterday, CannTrust announced a voluntary hold on the sale and shipment of all cannabis products as a precaution while Health Canada visits and reviews its Vaughan, Ont.-based manufacturing facility

The cannabis company also announced that an independent special committee of CannTrust’s board of directors has been established to “investigate this matter in its entirety.”

WATCH: CannTrust marijuana producer on pot shortages, cannabis legalization and product innovation

GanjaTours

Next Post

COMMENTARY: Canada’s legal pot market is gaining strength, but still has far to go

Sat Jul 13 , 2019
Canada’s cannabis legalization has had its problems. For example, last week the Ontario and federal governments blamed each other for the shortage of legal retailers in that province. This week, a producer was caught growing cannabis in unlicensed facilities. And Statistics Canada reports most users still buy from illegal suppliers. […]